Category: Immunodeficiency: primary or acquired

F.64 - Phenotypic and Functional Defects Underlie Ineffective Control of Ebv in Patients with Distinct Primary Immunodeficiencies

Friday, Jun 16
6:15 PM – 7:30 PM

Hassan Abolhassani

Karolinska Institutet at Karolinska University Hospital Huddinge
Stockholm, Stockholms Lan, Sweden

Asghar Aghamohammadi

Children's Medical Centre
Tehran, Tehran, Iran

Kaan Boztug

CeMM Research Center fo Molecular Medicine of the AUstrian Academy of Sciences
Vienna, Vorarlberg, Austria

Sharon Choo

Royal Children's Hospital
Melbourne, Victoria, Australia

Theresa Cole

Royal Children's Hospital
Melbourne, Victoria, Australia

Matthew Cook

Australian National Univeristy
Canberra, Australian Capital Territory, Australia

Graham Davies

Great Ormond Street Hospital
London, England, United Kingdom

Figen Dogu

Ankara University Medical School
Ankara, Ankara, Turkey

Gregor Ducker

HELIOS Clinic
Krefeld, Nordrhein-Westfalen, Germany

Emma Gostick

Cardiff University
Cardiff, Wales, United Kingdom

Lennart Hammarstrom

Karolinska Institutet at Karolinska University Hospital Huddinge
Stockholm, Stockholms Lan, Sweden

Sule Haskologlu

Ankara University Medical School
Ankara, Ankara, Turkey

Aydan Ikinciogullari

Ankara University Medical School
Ankara, Ankara, Turkey

Sevgi Kostel Bal

Ankara University Medical School
Ankara, Ankara, Turkey

Michael Lenardo

Senior Investigator
NIH
Bethesda, Maryland

Michael Joseph Lenardo, M.D.
Michael Lenardo was born in Chicago, Illinois on December 1, 1955. He attended the Johns Hopkins University and graduated with a Bachelor of Arts in Natural Sciences in 1977. He attended Washington University St. Louis, Mo. and obtained his Doctor of Medicine (M.D.) in 1981. He carried out clinical and research training at the University of Iowa from 1981-1985. He was then a Research Fellow at the Whitehead Institute for Biomedical Research at Massachusetts Institute of Technology with an adjunct appointment at Harvard Medical School. During this time, he carried out molecular biology research under the mentorship of Nobel laureates David Baltimore and Philip Sharp. He was then appointed Section Chief in the National Institute of Allergy and Infectious Diseases, National Institutes of Health from 1989 to the present, directing research on T-lymphocyte regulation, HIV-1, and genetic diseases of the immune system. Dr. Lenardo has published over 200 scholarly works and holds a number of medical patents. He discovered the propriocidal mechanism of immune regulation and his work has defined several genetic diseases of the immune system including the Autoimmune Lymphoproliferative Syndrome, Caspase-8 deficiency syndrome, and X-linked magnesium deficiency with EBV and neoplasia (XMEN) disease. He is currently the Director of the Clinical Genomics Program and Chief of the Molecular Development Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health. He is a Fellow of the American Association for the Advancement of Science and the American Academy of Arts and Sciences.

Qiang Pan Hammarstrom

Karolinska Institutet at Karolinska University Hospital Huddinge
Stockholm, Stockholms Lan, Sweden

David Price

Cardiff Univrsity
Cardiff, Wales, United Kingdom

Nima Rezaei

Children's Medical Centre
Tehran, Tehran, Iran

Helen S Su

NIH
Bethesda, Maryland

Nurdan Tacyildiz

Ankara University Medical School
Ankara, Ankara, Turkey

Stuart Tangye

Garvan Institute
Darlinghurst, New South Wales, Australia

Gulbu Uzel

NIH
Bethesda, Maryland

Melanie Wong

Royal Children's Hospital
Melbourne, Victoria, Australia

Emily S J.. Edwards

Garvan Institute of Medical Research
Sydney, New South Wales, Australia